Inventor · disambiguated record
David White
Also filed as: WHITE DAVID · WHITE DAVID W · WHITE DAVID WILLIAM
16 granted patents·38 pending applications·250 citations·filing 1996–2024
94Inventor score
Files withMILLENNIUM PHARM INC30ORE PHARMACEUTICALS INC6REVOLUTION MEDICINES INC4MILLENIUM PHARMACEUTICALS INC3GENE LOGIC INC2
Top patents by PatentIndex Score
54 records- 0197US10989710B2Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2018·Granted Apr 27, 2021·14 cites·6 claims
- 0297US10203323B2Identifying new therapeutic agentsWARP DRIVE BIO INC·Filed 2016·Granted Feb 12, 2019·21 cites·6 claims
- 0397US9428845B1Identifying new therapeutic agentsVERDINE GREGORY L·Filed 2011·Granted Aug 30, 2016·28 cites·8 claims
- 0495US11644460B2Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2020·Granted May 9, 2023·8 cites·10 claims
- 0592US6977240B1Methods of using the OB receptor antibodies to treat bodyweight disordersMILLENIUM PHARMACEUTICALS INC·Filed 2001·Granted Dec 20, 2005·26 cites·6 claims
- 0689US2025076289A1Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2024·Application pending·0 cites
- 0788US6395498B1Methods of identifying compounds that modulate body weight using the OB receptorMILLENNIUM PHARM INC·Filed 1997·Granted May 28, 2002·68 cites·20 claims
- 0885US2024044876A1Identifying new therapeutic agentsREVOLUTION MEDICINES INC·Filed 2023·Application pending·0 cites
- 0980US7842709B2Method for treating inflammatory diseases of the digestive tractORE PHARMACEUTICALS INC·Filed 2007·Granted Nov 30, 2010·8 cites·19 claims
- 1074US6146876A22025, a novel human cyclic nucleotide phosphodiesteraseMILLENNIUM PHARM INC·Filed 1999·Granted Nov 14, 2000·40 cites·8 claims
- 1170US2011020798A1Novel italy, LOR-2, strife, trash, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1265US2008248477A1Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1365US2010136010A1Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1465US2004176296A1Novel ITALY, LOR-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 1563US2008108093A1Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1663US2008113399A1Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 1761US6444802B1Human aminopeptidaseMILLENIUM PHARMACEUTICALS INC·Filed 1999·Granted Sep 3, 2002·13 cites·14 claims
- 1860US2009226450A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 1959US7235634B22786, a novel human aminopeptidaseBAYER HEALTHCARE AG·Filed 2004·Granted Jun 26, 2007·0 cites·7 claims
- 2059US2002182676A1Ob receptor and methods for the diagnosis and treatment of body weight disorders, including obesity and cachexiaMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 2158US2006009632A1Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2005·Application pending·0 cites
- 2258US2004086921A157242, a novel human G protein-coupled receptor family member and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2357US6380363B1Antibodies to the Ob receptorFiled 1998·Granted Apr 30, 2002·11 cites·11 claims
- 2456US7547515B2Methods for detection of the Ob receptor and the diagnosis of body weight disorders, including obesity and cachexiaMILLENNIUM PHARM INC·Filed 2005·Granted Jun 16, 2009·0 cites·17 claims
- 2556US2003224417A114400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptorsMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2656US2009012052A1Method for treating er+ breast cancerORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2755US2004110204A1Compositions, kits,and methods for prognostication, diagnosis, prevention, and treatment of bone-related disorders and other disordersMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 2855US2002072089A1Novel ITALY, Lor-2, STRIFE, TRASH, BDSF, LRSG, and STMST protein and nucleic acid molecules and uses thereforFiled 2001·Application pending·0 cites
- 2955US2008051322A114400, 2838, 14618, 15334, 14274, 32164, 39404, 38911, 26904, 31237, 18057, 16405, 32705, 23224, 27423, 32700, 32712 and 12216, novel seven-transmembrane proteins/G-protein coupled receptorsMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 3054US2003232044A1Use for endothelin converting enzyme 2 (ECE-2) in the diagnosis and treatment of metabolic disordersMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 3154US2009192220A1Treatment for solid tumorsORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3254US2007281306A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 3354US2009186014A1Method for treatment of pancreatitisORE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3453US2002137063A157242, a novel human G protein-coupled receptor family member and uses thereforMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 3553US2024285785A1Targeting sortilinPROTEINQURE INC·Filed 2023·Application pending·0 cites
- 3652US2002127694A12786, a novel human aminopeptidaseMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3751US2003165490A122196, a novel human aminopeptidaseMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3851US2003165491A122196, a novel human aminopeptidaseMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 3950US2004067513A184569, a novel human map kinase family member and uses thereforMILLENNIUM PHARM INC·Filed 2003·Application pending·0 cites
- 4049US6403552B1Ob receptor and methods for the diagnosis and treatment of body weight disordersMILLENIUM PHARMACEUTICALS INC·Filed 1998·Granted Jun 11, 2002·7 cites·41 claims
- 4148US2010029734A1Methods for breast cancer screening and treatmentORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4247US2011171205A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 4346US2002076796A12786, a novel human aminopeptidaseMILLENNIUM PHARMACEUTICALS·Filed 2001·Application pending·0 cites
- 4445US2008132474A1Breast cancer screening and treatment methodsGENE LOGIC INC·Filed 2007·Application pending·0 cites
- 4544US2003092041A1Novel use for muscarinic receptor M5 in the diagnosis and treatment of metabolic disordersMILLENNIUM PHARM INC·Filed 2002·Application pending·0 cites
- 4643US2008234345A1Method for reducing or alleviating inflammation in the digestive tractGENE LOGIC INC·Filed 2007·Application pending·0 cites
- 4743US2010069400A1Methods for treating inflammation and related conditionsORE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4843US2010105746A1Method for treating metabolic diseasesCLISH CLARY·Filed 2009·Application pending·0 cites
- 4941US2012009183A1Method for treatment of pancreatitisTARTAGLIA LOUIS ANTHONY·Filed 2011·Application pending·0 cites
- 5041US2001024808A1Leptin induced genesMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →